CN Stock MarketDetailed Quotes
300026 Tianjin Chase Sun Pharmaceutical
- 4.07
- +0.47+13.06%
Market Closed Sep 30 15:00 CST
12.23BMarket Cap39.51P/E (TTM)
4.11High3.68Low1.83MlotVolume3.71Open3.60Pre Close713.41MTurnover6.81%Turnover Ratio24.08P/E (Static)3.00BShares4.9152wk High1.39P/B10.93BFloat Cap3.0152wk Low4.32Limit Up2.69BShs Float10.66Historical High2.88Limit Down11.94%Amplitude1.16Historical Low0.03Dividend TTM3.90Avg Price697.21KlotAsk0.74%Div YieldTTM100Lot Size1.11MlotBid
Tianjin Chase Sun Pharmaceutical Key Stats
All
YOY
| (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | (Q3)Mar 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total operating revenue | -12.48%3B | -11.80%1.46B | -8.14%6.11B | 0.45%4.92B | 3.38%3.42B | -4.23%1.66B | -13.30%6.65B | -10.68%4.9B | -5.01%3.31B | 5.70%1.73B |
| Operating revenue | -12.48%3B | -11.80%1.46B | -8.14%6.11B | 0.45%4.92B | 3.38%3.42B | -4.23%1.66B | -13.30%6.65B | -10.68%4.9B | -5.01%3.31B | 5.70%1.73B |
| Other operating revenue | -63.44%7.23M | ---- | 77.73%84.31M | ---- | 365.55%19.76M | ---- | 224.26%47.44M | ---- | 7.65%4.25M | ---- |
| Total operating cost | -7.79%2.8B | -7.48%1.37B | -5.57%5.59B | 0.03%4.39B | 3.10%3.04B | -1.12%1.48B | -10.73%5.92B | -6.74%4.39B | -0.16%2.95B | 5.71%1.49B |
| Operating cost | -3.93%1.41B | 0.15%713.22M | -0.28%2.8B | 0.05%2.2B | -4.78%1.47B | -9.76%712.16M | -12.88%2.81B | -11.12%2.2B | -0.70%1.54B | 8.10%789.17M |
| Operating tax surcharges | 11.01%32.84M | 24.45%15.55M | -6.27%57.84M | 6.40%43.89M | 2.74%29.58M | -24.23%12.49M | -19.26%61.72M | -14.90%41.25M | -10.30%28.79M | 24.37%16.49M |
| Operating expense | -12.84%1.04B | -16.80%478.57M | -12.58%2.03B | -0.44%1.62B | 15.36%1.2B | 9.73%575.21M | -11.33%2.32B | -4.89%1.63B | -3.02%1.04B | 0.57%524.19M |
| Administration expense | -6.27%204.16M | -4.81%105.08M | 0.68%438.24M | 6.90%330.43M | 7.78%217.82M | 16.40%110.39M | -3.41%435.27M | -1.15%309.11M | 2.75%202.08M | -0.18%94.84M |
| Financial expense | -27.70%19.5M | -40.64%10.35M | -14.61%45.71M | 18.38%36.41M | 3.64%26.97M | -4.24%17.44M | -5.19%53.53M | -19.92%30.76M | 6.65%26.02M | 38.65%18.21M |
| -Interest expense (Financial expense) | -14.89%28.58M | -10.92%15.21M | -11.62%61.57M | -6.03%46.26M | -5.50%33.58M | 0.94%17.08M | 39.05%69.67M | 45.30%49.23M | 86.49%35.53M | 37.67%16.92M |
| -Interest Income (Financial expense) | -21.16%-9.61M | -53.17%-5.54M | -75.18%-19.31M | -37.89%-12.27M | -34.13%-7.93M | -19.47%-3.61M | 3.13%-11.02M | -16.08%-8.9M | -20.63%-5.91M | -16.30%-3.03M |
| Research and development | -7.41%93.69M | -11.24%44.36M | -8.91%215.59M | -12.51%154.07M | -10.51%101.19M | -3.09%49.98M | 16.39%236.69M | 52.06%176.09M | 44.21%113.08M | 25.52%51.57M |
| Credit Impairment Loss | -1,572.18%-37.95M | -310.01%-25.03M | 17.53%-65.49M | -20.47%-28.85M | 78.39%-2.27M | 505.84%11.92M | 10.63%-79.41M | 37.62%-23.95M | 39.64%-10.5M | -634.47%-2.94M |
| Asset Impairment Loss | -11.65%-6.35M | 17.11%-2.27M | -684.44%-37.63M | -89.29%-5.87M | -116.75%-5.68M | -394.45%-2.74M | 94.54%-4.8M | -6.66%-3.1M | -78.85%-2.62M | 2,973.89%929.17K |
| Other net revenue | -291.36%-27.3M | -220.83%-20.24M | -59.36%-31.03M | -74.27%6.91M | -39.11%14.26M | -15.58%16.75M | 88.24%-19.47M | 188.99%26.87M | 333.77%23.43M | 484.28%19.84M |
| Invest income | -46.70%-1.23M | 52.80%-245.33K | -144.35%-1.4M | -141.60%-474.06K | -179.37%-841.02K | -140.40%-519.77K | 113.75%3.16M | -23.20%1.14M | -35.73%1.06M | 3,323.06%1.29M |
| -Including: Investment income associates | -46.70%-1.23M | 52.80%-245.33K | -76.39%464.52K | -140.45%-461.06K | -179.37%-841.02K | -140.40%-519.77K | 0.38%1.97M | -23.12%1.14M | -35.73%1.06M | 3,323.06%1.29M |
| Asset deal income | 1,192.64%574.69K | 107.45%3.13K | 20,693.52%1.06M | -60.12%-293.25K | 74.84%-52.6K | 79.91%-42K | 100.18%5.11K | 93.62%-183.14K | 91.30%-209.07K | 91.62%-209.07K |
| Other revenue | -23.61%17.66M | -10.16%7.3M | 17.64%72.43M | -19.94%42.4M | -35.26%23.11M | -60.87%8.13M | 66.78%61.57M | 323.81%52.96M | 271.95%35.7M | 233.82%20.77M |
| Operating profit | -58.54%164.31M | -61.64%76M | -31.33%489.27M | 0.14%542.78M | 2.94%396.31M | -23.14%198.15M | -18.59%712.52M | -28.14%542.01M | -26.16%385.01M | 12.77%257.8M |
| Add:Non operating Income | -35.24%10.72M | -92.57%1.2M | 203.47%125.81M | 65.22%57.21M | -33.34%16.55M | -40.45%16.2M | 185.04%41.46M | 124.31%34.63M | 71.93%24.83M | 1,149.08%27.21M |
| Less:Non operating expense | 8.49%5.13M | 18.94%269.47K | -78.05%8.25M | 11.08%5.96M | 18.46%4.73M | -73.33%226.56K | 5.77%37.61M | 54.75%5.36M | 71.69%3.99M | -27.39%849.36K |
| Total profit | -58.37%169.9M | -64.07%76.93M | -15.29%606.82M | 3.98%594.03M | 0.56%408.13M | -24.65%214.12M | -16.13%716.37M | -25.44%571.27M | -23.94%405.84M | 23.75%284.16M |
| Less:Income tax cost | -70.41%17.28M | -36.21%22.54M | 10.64%105.25M | -19.34%82.07M | 3.72%58.4M | -20.36%35.33M | -48.10%95.14M | -26.74%101.76M | -45.54%56.31M | 12.97%44.36M |
| Net profit | -56.36%152.61M | -69.57%54.4M | -19.26%501.57M | 9.04%511.96M | 0.06%349.73M | -25.44%178.79M | -7.40%621.23M | -25.15%469.52M | -18.74%349.54M | 25.97%239.8M |
| Net profit from continuing operation | -56.36%152.61M | -69.57%54.4M | -19.26%501.57M | 9.04%511.96M | 0.06%349.73M | -25.44%178.79M | -7.40%621.23M | -25.15%469.52M | -18.74%349.54M | 25.97%239.8M |
| Less:Minority Profit | 13.57%4.38M | -211.50%-3.72M | -68.36%-5.06M | 412.84%2.78M | 224.08%3.86M | 113.95%3.34M | 81.74%-3.01M | 90.91%-889.31K | 59.58%-3.11M | 155.62%1.56M |
| Net profit of parent company owners | -57.14%148.23M | -66.87%58.12M | -18.84%506.63M | 8.24%509.18M | -1.92%345.87M | -26.35%175.45M | -9.18%624.24M | -26.16%470.41M | -19.46%352.65M | 23.34%238.24M |
| Earning per share | ||||||||||
| Basic earning per share | -58.33%0.05 | -66.67%0.02 | -19.05%0.17 | 6.25%0.17 | 0.00%0.12 | -25.00%0.06 | -8.70%0.21 | -23.81%0.16 | -20.00%0.12 | 33.33%0.08 |
| Diluted earning per share | -58.33%0.05 | -66.67%0.02 | -19.05%0.17 | 6.25%0.17 | 0.00%0.12 | -25.00%0.06 | -8.70%0.21 | -23.81%0.16 | -20.00%0.12 | 33.33%0.08 |
| Other composite income | -88.74%821.47K | 86.39%-422.15K | -70.88%3.89M | -73.28%5.44M | 18.69%7.3M | -170.83%-3.1M | 73.07%13.37M | 1,064.79%20.35M | 483.28%6.15M | -295.13%-1.15M |
| Other composite income of parent company owners | -88.74%821.47K | 86.39%-422.15K | -70.88%3.89M | -73.28%5.44M | 18.69%7.3M | -170.83%-3.1M | 73.07%13.37M | 1,064.79%20.35M | 483.28%6.15M | -295.13%-1.15M |
| Total composite income | -57.02%153.44M | -69.28%53.98M | -20.35%505.46M | 5.62%517.4M | 0.38%357.03M | -26.38%175.69M | -6.48%634.61M | -22.13%489.87M | -17.00%355.69M | 24.99%238.65M |
| Total composite income of parent company owners | -57.80%149.05M | -66.52%57.7M | -19.93%510.53M | 4.86%514.62M | -1.57%353.17M | -27.31%172.35M | -8.26%637.62M | -23.18%490.76M | -17.75%358.79M | 22.37%237.09M |
| Total composite income of minority owners | 13.57%4.38M | -211.50%-3.72M | -68.36%-5.06M | 412.84%2.78M | 224.08%3.86M | 113.95%3.34M | 81.74%-3.01M | 90.91%-889.31K | 59.58%-3.11M | 155.62%1.56M |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- | -- |
| Auditor | -- | -- | Shinnaganaka & Chung Certified Public Accountants (Special General Partnership) | -- | -- | -- | Shinnaganaka & Chung Certified Public Accountants (Special General Partnership) | -- | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Analysis
Price Target
No Data
Heat List
CN
Overall
Symbol
Latest Price
% Chg
No Data